货号:GS40147
Coprelotamab (GB-221) is an investigational IgG-κ monoclonal antibody developed as a targeted therapy for solid tumors. It is designed to specifically bind to and inhibit the activity of a receptor tyrosine kinase that is overexpressed in certain cancers, such as breast and gastric cancers. As a monoclonal antibody, its primary mechanism is to block the signaling pathways that drive tumor cell proliferation and survival.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯